Carroll McLeod, MD
Pain Medicine · Jackson, MSNPI 1245383033
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,516 of the $6,900 with a category attached, or 79.9%. 24 manufacturers reported payments, led by Nevro Corp. at 29.6% of the total. Reporting peaked in 2019 at $3,152 and has fallen 85.9% since, to $444 in 2025.
Across 179 payments — averaging $38.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$2K
- Boston Scientific$2K
- Abbott$923
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$521
- Nalu Medical, Inc.$495
- Pfizer$302
- plus $720 from 18 others
Across 7 payments — averaging $11,678 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GRT US Holding, Inc.$75K
- Regeneron$6K
- Flowonix Medical Incorporated$750
What the payments were for
- Travel & lodging$1,38520%
- Food & beverage$5,51680%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 20 | $2,042 |
| Boston Scientific | 86 | $1,897 |
| Abbott | 11 | $923 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $521 |
| Nalu Medical, Inc. | 9 | $495 |
| Pfizer | 14 | $302 |
| Corelink, LLC | 1 | $112 |
| Collegium Pharmaceutical, Inc. | 5 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $83 |
| Johnson & Johnson | 2 | $59 |
| Globus Medical | 2 | $56 |
| Stryker | 1 | $53 |
| Redhill Biopharma Inc. | 3 | $52 |
| Baudax Bio Inc. | 2 | $44 |
| Piramal Critical Care | 2 | $29 |
| AstraZeneca | 2 | $23 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Innovation Technologies Inc | 1 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Si-bone, Inc. | 1 | $16 |
| GRT US Holding, Inc. | 1 | $14 |
| Curonix LLC | 1 | $13 |
| Hologic Sales And Service, LLC | 1 | $13 |
| Biodelivery Sciences International, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,900 in reported general payments places this provider in the 65th percentile of 48 pain medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 12 | $8,674 |
| Diclofenac Sodium | 74 | $880 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 63 | $721 |
| Methylprednisolone | 106 | $588 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 30 | $502 |
| Gabapentin | 46 | $349 |
| Tramadol Hcl | 45 | $215 |
| Cephalexin | 34 | $157 |
| Meloxicam | 68 | $146 |
| Methocarbamol | 26 | $132 |
| Pregabalin | 23 | $125 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $17 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $83 | $8,67412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 48 pain medicine providers in Mississippi.
Other pain medicine in Jackson
- Casey OrzechowiczJackson$15K
- Anand PremJackson$13K
- Anesh RugnathJackson$10K
- Arvind ChandrashekarJackson$4K
- Ikechukwui EriatorJackson$2K
- William GusaJackson$2K
- Joel NuttJackson$1K
- Kristen BellJackson$339
- Veronica CarulloJackson$261
- Mansoor HasanJackson$18
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.